Recovery from immune therapy-related hypothyroidism
Part of Hormones & metabolism clinical trials.
This trial looks at whether patients can recover from low thyroid function caused by immune checkpoint inhibitor drugs. If you've finished immune therapy and are on thyroid medication, you may be able to stop or reduce it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 19 years or older
- You were treated with an immune checkpoint inhibitor (a type of cancer drug that helps your immune system attack cancer)
- You developed an underactive thyroid (hypothyroidism) as a side effect of that treatment and started taking levothyroxine (a thyroid hormone medication)
- You have stopped immune checkpoint inhibitor therapy before joining this study
- You did not take any thyroid medication or antithyroid drugs in the 3 months before starting immune therapy
- You have no history of thyroid surgery, radioactive iodine treatment, or radiation to your neck
- Your current dose of levothyroxine is less than 0.1 mg per day
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new approach for people with hypothyroidism who are already taking levothyroxine. You may be able to join if you are on a certain dose and do not have other health conditions that could affect the results.
This study looks at whether it is safe to stop taking a low dose of levothyroxine (a thyroid hormone pill) in people aged 65 and older who have a mildly underactive thyroid. If you have been on this medication for at least 6 months, you may be able to help doctors learn if stopping the pill is a good option.
This study is testing whether it’s safe to slowly reduce or stop thyroid hormone medication in older adults who may not need it. The goal is to improve health and avoid unnecessary treatment.
This study compares two ways of replacing thyroid hormone after radioactive iodine therapy for high-risk thyroid cancer. It aims to find which approach is more effective and better for patients.
This study tests a new way of providing thyroid hormone therapy for people who still feel tired and other bothersome symptoms despite currently taking a standard thyroid pill (levothyroxine). It combines two types of thyroid hormone (T4 and T3) to see if it better relieves symptoms than the usual treatment.
This study tests whether using treatment to keep thyroid-stimulating signals low during radiation to the thyroid area can help prevent a treatment-related drop in thyroid function in children. It is aimed at kids with certain cancers whose radiation plan includes thyroid tissue.
Hear when a new Hypothyroidism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.